Relypsa Soars on Positive Phase 1 Results
Relypsa rose early in Monday’s session as the result of positive results from its Phase 1 in vivo studies evaluating the interactions between Veltassa (patiromer) and other drugs.
All Work
Chris Lange
Lockheed Martin Investors Not Impressed With Earnings Beat
Lockheed Martin released a mixed fourth-quarter financial report before the markets opened on Tuesday.
Procter & Gamble Earnings Top Estimates
Procter & Gamble reported mixed fiscal second-quarter financial results before the markets opened on Tuesday.
Johnson & Johnson Kicks Off 2016 With Solid Earnings and Guidance
Johnson & Johnson reported its fourth-quarter financial results before the markets opened on Tuesday.
Staples Shakes Up Leadership in 2016
Staples, in an effort to streamline its organization and build a more simple structure going forward, has announced a few leadership changes.
Procter & Gamble Q2 Earnings: What to Expect
Procter & Gamble is scheduled to release its fiscal second-quarter financial results before the markets open on Tuesday.
What to Look for in Johnson & Johnson Earnings
Johnson & Johnson is set to release its fourth-quarter financial results before the markets open Tuesday.
What to Expect From 3M Earnings
3M is scheduled to report its fourth-quarter financial results before the markets open Tuesday.
Could This Merck Deal Be the Turning Point for Affimed?
Affimed shares rose on Monday following the announcement of a collaboration in immuno-oncology with biotech giant Merck.
Albertsons Updates Finances in Most Recent IPO Filing
Albertsons expects to price more than 65 million shares in the range of $23 to $26 in an IPO valued up to nearly $2 billion.
Tyco and Johnson Controls Set for Merger and Tax Inversion
Tyco International and Johnson Controls have announced that they have entered into a definitive merger agreement to create a leader in building products and technology, integrated solutions and energy storage.
Why OncoMed’s Update Could Crater the Stock
OncoMed Pharmaceuticals saw its stock sink early Monday morning following an update from its Phase 2 Alpine study.
How McDonald’s Took a Big Bite Out of Earnings
McDonald's reported better-than-expected fourth-quarter financial results before the markets opened on Monday.
Top DJIA Earnings for the Week Ahead
24/7 Wall St. has put together a preview of some of the Dow Jones Industrial Average companies (and others) that are reporting their quarterly results this week.
4 Stocks That Punished Shareholders Last Week
While these were not the four biggest absolute losers of the week, they all issued news or had news that took place and pushed the stocks down.
Agile Therapeutics Announces Pricing for Secondary Offering
Agile Therapeutics fell in Friday’s session, despite the broad markets taking off, after the company announced the pricing for its secondary offering.
Golar LNG Soars on Schlumberger Memorandum
According to a new memorandum of understanding, Golar and Schlumberger have agreed to jointly market gas monetization solutions to owners, investors and governments.
Why 2 Lululemon Analysts Are Now Even More Bullish
Lululemon Athletica received a few key analyst calls early on Friday that took a more bullish stance on the stock.
Why SolarCity Received an Investment Grade Rating
SolarCity completed its first securitization of distributed solar loan assets early Friday, the company's fifth securitization transaction to date.
Synchrony Posts Solid Earnings Beat
Synchrony Financial reported its fourth-quarter financial results before the markets opened on Friday.